Start a Radiofrequency Ablation Device Company

1. 1

   Design the generator-plus-probe system

   RFA for pain uses a capital generator paired with single-use probes to ablate nerves (for example medial branch nerves in facet-related back pain). Design a system with a clinical or technical edge, cooled probes, better lesion control, multi-lesion efficiency, or a cost advantage, because the market has established players. The single-use probe is the recurring-revenue heart of the model. Design the disposable and the generator as one economic system.

2. 2

   Pursue the appropriate FDA pathway

   Many RFA devices can pursue the 510(k) clearance pathway by demonstrating substantial equivalence to a predicate device, which is faster and cheaper than the PMA route implantables require, though the exact pathway depends on the design and claims. Confirm classification and pathway with regulatory counsel early. A tractable regulatory route is part of what makes this niche more accessible than SCS. Design controls and testing still apply rigorously.

3. 3

   Build quality-system manufacturing

   You will manufacture both capital generators and high-volume sterile single-use probes, so an ISO 13485 quality system, sterile processing, and reliable supply chain are essential. The disposable line especially must be high-yield and consistent because it is the recurring revenue and any sterility failure is serious. Contract manufacturing is common for the disposables. Quality and cost per probe drive the model's economics.

4. 4

   Place capital, sell the disposables

   The go-to-market mirrors razor-and-blade: get generators into pain clinics and ASCs (sold, leased, or placed), then earn recurring revenue on every procedure's probe. Placement deals lower the customer's capital barrier and lock in probe purchases. Track the installed base and the pull-through per generator as your core metrics. The installed base is the annuity.

5. 5

   Support procedures and prove outcomes

   Physicians adopt devices they trust, so clinical training, procedural support, and evidence of consistent, effective lesions drive adoption and repeat probe purchases. Reimbursement for RFA procedures is established, which helps, but your device must perform reliably case after case. Field support and outcomes data are the retention engine. Reliability protects the recurring revenue that justifies the whole business.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.